135214-83-4

Basic information

• Product Name: 1,5-Anhydro-2-deoxy-4,6-O-(phenylmethylene)-D-arabino-hexopyranoside
• Synonyms: 1,5-Anhydro-2-deoxy-4,6-O-(phenylmethylene)-D-arabino-hexopyranoside
• CAS NO: 135214-83-4
• Molecular Weight: 236.268
• Mol File: 135214-83-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 1,5-Anhydro-2-deoxy-4,6-O-(phenylmethylene)-D-arabino-hexopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: 1,5-Anhydro-2-deoxy-4,6-O-(phenylmethylene)-D-arabino-hexopyranoside(135214-83-4)
• EPA Substance Registry System: 1,5-Anhydro-2-deoxy-4,6-O-(phenylmethylene)-D-arabino-hexopyranoside(135214-83-4)

Safety Data

• Hazardous Substances Data: 135214-83-4(Hazardous Substances Data)

Upstream product

• 1125-88-8 benzaldehyde dimethyl acetal 
• 3971-47-9 (3S,4R)-dihydroxy-(2R)-(hydroxymethyl)tetrahydropyran 
• 13035-12-6 3,4,6-tri-O-acetyl-1,2-dideoxy-D-glucopyranose 
• 7103-29-9 1,2-dideoxy-D-allose 
• 100-52-7 benzaldehyde 

Downstream Products

• 252896-22-3 Acetic acid (2R,3S,4S,5R,6R)-3,5-diacetoxy-2-acetoxymethyl-6-((2R,4aR,8R,8aS)-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yloxy)-tetrahydro-pyran-4-yl ester 
• 334022-44-5 tert-Butyl-[4-methoxy-3-((2R,4aR,8R,8aS)-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yloxy)-benzyloxy]-dimethyl-silane 
• 291273-52-4 (2R,4aR,8R,8aS)-8-(2-Methoxy-phenoxy)-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxine 
• 438216-14-9 3-O-benzoyl-4,6-O-benzylidene-1,2-dideoxy-D-glucopyranose 
• 135214-84-5 (-)-(1S,3R,6R,10R)-10-(t-Butyldimethylsiloxy)-3-phenyl-2,4,7-trioxabicyclo<4.4.0>decane 
• 557767-29-0 1,5-anhydro-2-deoxy-3-O-[2,4-di-O-benzoyl-3-O-(2-ethoxy-2-oxoethyl)-6-O-(phenylmethyl)-β-D-galactopyranosyl]-4,6-O-(phenylmethylene)-D-arabino-hexitol 
• 557767-31-4 1,5-anhydro-2-deoxy-3-O-[2,4-di-O-benzoyl-3-O-(2-ethoxy-2-oxoethyl)-6-O-(phenylmethyl)-β-D-galactopyranosyl]-6-O-(phenylmethyl)-D-arabino-hexitol 
• 557767-33-6 O-2,4-di-O-benzoyl-3-O-(2-ethoxy-2-oxoethyl)-6-O-(phenylmethyl)-β-D-galactopyranosyl-(1->3)-O-[6-deoxy-2,3,4-tris-O-(phenylmethyl)-α-L-galactopyranosyl-(1->4)]-1,5-anhydro-2-deoxy-6-O-(phenylmethyl)-D-arabino-hexitol 
• 334022-48-9 4-Methoxy-3-((2R,4aR,8R,8aS)-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yloxy)-benzaldehyde 
• 334022-50-3 [3-((2R,3S,4R)-3-Hydroxy-2-hydroxymethyl-tetrahydro-pyran-4-yloxy)-4-methoxy-phenyl]-phenyl-methanone 
• 334022-47-8 [4-Methoxy-3-((2R,4aR,8R,8aS)-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yloxy)-phenyl]-methanol 
• 334022-49-0 [4-Methoxy-3-((2R,4aR,8R,8aS)-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yloxy)-phenyl]-phenyl-methanol 
• 334022-45-6 [4-Methoxy-3-((2R,4aR,8R,8aS)-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yloxy)-phenyl]-phenyl-methanone 
• 334022-46-7 Toluene-4-sulfonic acid (2R,3S,4R)-4-(5-benzoyl-2-methoxy-phenoxy)-3-hydroxy-tetrahydro-pyran-2-ylmethyl ester 

Relevant articles and documents

GLYCOMIMETIC INHIBITORS OF SIGLEC-8

Compounds, compositions and methods are provided for detecting or modulating in vitro and in vivo processes mediated by Siglec-8 binding. More specifically, Siglec-8 modulators and their use are described, wherein the Siglec-8 modulators that modulate a S

Identifying specific conformations by using a carbohydrate scaffold: Discovery of subtype-selective LPA-receptor agonists and an antagonist

Stable and potent subtype-selective lysophosphatidic acid (LPA) analogues (agonists and an antagonist) were developed by using carbohydrates as a core structure (see scheme). An array of molecules with the recognition motifs of LPA (a phosphate anion, an oleoyl group, and a hydrogen-bond acceptor) attached to carbohydrate isomers in different three-dimensional arrangements were tested for LPA-receptor activation or inhibition. R = alkyl.

Synthesis and Biological Evaluation of a Potent E-Selectin Antagonist

An early step of the inflammatory response - the rolling of leukocytes on activated endothelial cells - is mediated by selectin/carbohydrate interactions. The tetrasaccharide sialyl Lewisx (sLex) 1 is a ligand for E-, P-, and L-selectin and, therefore, serves as a lead structure to develop analogues which allow the control of acute and chronic inflammation. Here we describe the efficient synthesis (10 linear steps) of the potent sLex mimetic 2. Compared to sLex, compound 2 showed a 30-fold improved affinity in a static, cell-free E-selectin-ligand binding assay (IC50 = 36 μM). These data were confirmed by a marked inhibition in an in vitro cell-cell rolling assay which simulates in vivo conditions (IC50 ca. 40 μM). The assays are predictive for the in vivo efficacy of test compounds as indicated by a marked inhibitory effect of 2 in a thioglycollate induced peritonitis model of acute inflammation in mice (ED50 ca. 15 mg/kg).